Pivanex, a histone deacetylase inhibitor, induces changes in BCR-ABL expression and when combined with STI571, acts synergistically in a chronic myelocytic leukemia cell line

E. Rabizadeh, V. Merkin, I. Belyaeva, M. Shaklai, Y. Zimra

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Pivanex, a histone deacetylase inhibitor, induces changes in BCR-ABL expression and when combined with STI571, acts synergistically in a chronic myelocytic leukemia cell line'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science